The fourth is closely implicated in the gene expression of ZEB1 and alpha-fetoprotein (AFP), via targeting and competing miR-1236, whereas the fifth is implicated in HCC-resistance in sorafenib. This evidence concerns the gene AFP and hepatocellular carcinoma.